Centro de Hematologia e Hemoterapia - Hemocentro de Campinas - UNICAMP

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Haemophilia2 trials
• Acute myeloid leukaemia1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Pfizer2 trials
• Daiichi Sankyo1 trial

Running trials

• Active, not recruiting

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· Phase 3· Daiichi Sankyo· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

  NCT03861273· Phase 3· Pfizer· Source

Closed trials

• Completed

  A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

  NCT03587116· Phase 3· Pfizer· Source